These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19144953)

  • 1. Long-QT syndrome induced by the antiaddiction drug ibogaine.
    Hoelen DW; Spiering W; Valk GD
    N Engl J Med; 2009 Jan; 360(3):308-9. PubMed ID: 19144953
    [No Abstract]   [Full Text] [Related]  

  • 2. The anti-addiction drug ibogaine and the heart: a delicate relation.
    Koenig X; Hilber K
    Molecules; 2015 Jan; 20(2):2208-28. PubMed ID: 25642835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatalities temporally associated with the ingestion of ibogaine.
    Alper KR; Stajić M; Gill JR
    J Forensic Sci; 2012 Mar; 57(2):398-412. PubMed ID: 22268458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating drug dependence with the aid of ibogaine: a retrospective study.
    Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX
    J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibogaine for treating drug dependence. What is a safe dose?
    Schep LJ; Slaughter RJ; Galea S; Newcombe D
    Drug Alcohol Depend; 2016 Sep; 166():1-5. PubMed ID: 27426011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication development of ibogaine as a pharmacotherapy for drug dependence.
    Mash DC; Kovera CA; Buck BE; Norenberg MD; Shapshak P; Hearn WL; Sanchez-Ramos J
    Ann N Y Acad Sci; 1998 May; 844():274-92. PubMed ID: 9668685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibogaine-associated psychosis in schizophrenia: a case report.
    Houenou J; Homri W; Leboyer M; Drancourt N
    J Clin Psychopharmacol; 2011 Oct; 31(5):659. PubMed ID: 21881451
    [No Abstract]   [Full Text] [Related]  

  • 8. Life-threatening complications of ibogaine: three case reports.
    Paling FP; Andrews LM; Valk GD; Blom HJ
    Neth J Med; 2012 Nov; 70(9):422-4. PubMed ID: 23123541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences.
    Heink A; Katsikas S; Lange-Altman T
    J Psychoactive Drugs; 2017; 49(3):201-208. PubMed ID: 28266890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac arrest after ibogaine ingestion.
    Vlaanderen L; Martial LC; Franssen EJ; van der Voort PH; Oosterwerff E; Somsen GA
    Clin Toxicol (Phila); 2014 Jul; 52(6):642-3. PubMed ID: 24940646
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of death due to ibogaine use for heroin addiction: case report.
    Jalal S; Daher E; Hilu R
    Am J Addict; 2013; 22(3):302. PubMed ID: 23617876
    [No Abstract]   [Full Text] [Related]  

  • 12. Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence.
    Knuijver T; Belgers M; Markus W; Verkes RJ; van Oosteren T; Schellekens A
    J Clin Psychopharmacol; 2018 Dec; 38(6):646-648. PubMed ID: 30300292
    [No Abstract]   [Full Text] [Related]  

  • 13. Get Clean or Die Trying.
    Nestor J
    Sci Am; 2016 Oct; 315(5):62-69. PubMed ID: 27918503
    [No Abstract]   [Full Text] [Related]  

  • 14. The ibogaine medical subculture.
    Alper KR; Lotsof HS; Kaplan CD
    J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
    Popik P; Layer RT; Skolnick P
    Pharmacol Rev; 1995 Jun; 47(2):235-53. PubMed ID: 7568327
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.
    Luz M; Mash DC
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1019-1022. PubMed ID: 34139922
    [No Abstract]   [Full Text] [Related]  

  • 17. A non-hallucinogenic psychedelic analogue with therapeutic potential.
    Cameron LP; Tombari RJ; Lu J; Pell AJ; Hurley ZQ; Ehinger Y; Vargas MV; McCarroll MN; Taylor JC; Myers-Turnbull D; Liu T; Yaghoobi B; Laskowski LJ; Anderson EI; Zhang G; Viswanathan J; Brown BM; Tjia M; Dunlap LE; Rabow ZT; Fiehn O; Wulff H; McCorvy JD; Lein PJ; Kokel D; Ron D; Peters J; Zuo Y; Olson DE
    Nature; 2021 Jan; 589(7842):474-479. PubMed ID: 33299186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic literature review of clinical trials and therapeutic applications of ibogaine.
    Köck P; Froelich K; Walter M; Lang U; Dürsteler KM
    J Subst Abuse Treat; 2022 Jul; 138():108717. PubMed ID: 35012793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibogaine--be informed before you promote or prescribe.
    Galea S; Lorusso M; Newcombe D; Walters C; Williman J; Wheeler A
    J Prim Health Care; 2011 Mar; 3(1):86-7. PubMed ID: 21359272
    [No Abstract]   [Full Text] [Related]  

  • 20. Mania following use of ibogaine: A case series.
    Marta CJ; Ryan WC; Kopelowicz A; Koek RJ
    Am J Addict; 2015 Apr; 24(3):203-205. PubMed ID: 25877487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.